ATE356143T1 - Antibiotikum 107891, dessen faktoren a1 und a2, pharmazeutisch unbedenkliche salze und zusammensetzungen, und anwendung davon - Google Patents

Antibiotikum 107891, dessen faktoren a1 und a2, pharmazeutisch unbedenkliche salze und zusammensetzungen, und anwendung davon

Info

Publication number
ATE356143T1
ATE356143T1 AT04740916T AT04740916T ATE356143T1 AT E356143 T1 ATE356143 T1 AT E356143T1 AT 04740916 T AT04740916 T AT 04740916T AT 04740916 T AT04740916 T AT 04740916T AT E356143 T1 ATE356143 T1 AT E356143T1
Authority
AT
Austria
Prior art keywords
antibiotic
factors
compositions
pharmaceutically acceptable
acceptable salts
Prior art date
Application number
AT04740916T
Other languages
English (en)
Inventor
Ameriga Lazzarini
Luciano Gastaldo
Gianpaolo Candiani
Ismaela Ciciliato
Daniele Losi
Flavia Marinelli
Enrico Selva
Franco Parenti
Original Assignee
Vicuron Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vicuron Pharm Inc filed Critical Vicuron Pharm Inc
Application granted granted Critical
Publication of ATE356143T1 publication Critical patent/ATE356143T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04740916T 2003-07-18 2004-07-12 Antibiotikum 107891, dessen faktoren a1 und a2, pharmazeutisch unbedenkliche salze und zusammensetzungen, und anwendung davon ATE356143T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03016306 2003-07-18

Publications (1)

Publication Number Publication Date
ATE356143T1 true ATE356143T1 (de) 2007-03-15

Family

ID=34130026

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04740916T ATE356143T1 (de) 2003-07-18 2004-07-12 Antibiotikum 107891, dessen faktoren a1 und a2, pharmazeutisch unbedenkliche salze und zusammensetzungen, und anwendung davon

Country Status (12)

Country Link
US (1) US7307057B2 (de)
EP (1) EP1646646B1 (de)
JP (1) JP4163737B2 (de)
AR (1) AR046809A1 (de)
AT (1) ATE356143T1 (de)
BR (1) BRPI0412591A (de)
CA (1) CA2529124C (de)
DE (1) DE602004005203T2 (de)
ES (1) ES2281808T3 (de)
MX (1) MXPA06000691A (de)
TW (1) TWI340167B (de)
WO (1) WO2005014628A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7319088B2 (en) 2003-07-18 2008-01-15 Vicuron Pharmaceuticals Inc. Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
US7351687B2 (en) * 2003-07-18 2008-04-01 Vicuron Pharmaceuticals, Inc. Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
JP4189026B2 (ja) * 2005-01-12 2008-12-03 ヴィキュロン・ファーマシューティカルズ・インコーポレーテッド 抗生物質１０７８９１、そのａ１及びａ２因子、薬学的に許容されるその塩及び組成物、並びにその使用
WO2006075988A1 (en) 2005-01-12 2006-07-20 Vicuron Pharmaceuticals Inc. Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof
GB0600928D0 (en) 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
GB0714030D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
GB0714029D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
BRPI0721796A2 (pt) 2007-08-03 2012-03-13 Sentinella Pharmaceuticals, Inc. Ácido nucléico isolado, vetor de dna recombinante, célula hospedeira, método para aumentar a produção de 107891 ou de seus homólogos, microrganismo transformado, processo para produzir 107891, processo para produzir um precursor de 107891, método para produzir um lantibiótico diferente do 17891 e polipeptídeo isolado
US8283371B2 (en) 2009-01-14 2012-10-09 Novacta Biosystems Limited Compounds
EP2393829A1 (de) 2009-02-04 2011-12-14 Novacta Biosystems Limited Actagardinderivate
GB201001688D0 (en) 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
GB201013513D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations
JP2016501232A (ja) 2012-11-30 2016-01-18 ナイコンス，エセエッレエレＮａｉｃｏｎｓ，Ｓｒｌ 新規ランチビオティック誘導体およびその調製プロセス
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria
BR112020000196A2 (pt) 2017-07-07 2020-07-07 Epicentrx, Inc. composições para administração parenteral de agentes terapêuticos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59198982A (ja) 1983-04-28 1984-11-10 Meiji Seika Kaisha Ltd 新抗生物質ｓｆ−２２４０物質およびその製造法
EP0592835A3 (de) 1992-09-23 1995-03-15 Bristol Myers Squibb Co BU-4803T Antibiotika.
US6551591B1 (en) * 2001-09-07 2003-04-22 Essential Therapeutics, Inc. Antibiotics from microbispora

Also Published As

Publication number Publication date
WO2005014628A1 (en) 2005-02-17
DE602004005203D1 (de) 2007-04-19
US7307057B2 (en) 2007-12-11
BRPI0412591A (pt) 2006-09-19
TWI340167B (en) 2011-04-11
EP1646646A1 (de) 2006-04-19
DE602004005203T2 (de) 2007-11-22
JP4163737B2 (ja) 2008-10-08
EP1646646B1 (de) 2007-03-07
US20060183673A1 (en) 2006-08-17
MXPA06000691A (es) 2006-04-11
AR046809A1 (es) 2005-12-28
TW200510541A (en) 2005-03-16
CA2529124A1 (en) 2005-02-17
JP2007525479A (ja) 2007-09-06
CA2529124C (en) 2011-02-08
ES2281808T3 (es) 2007-10-01

Similar Documents

Publication Publication Date Title
IL175953A (en) Derivatives of 3-Cycloalkylaminopyrrolidine, their Pharmaceutical Salts and Preparations Containing Them
IL176005A0 (en) 2,6-bisheteroaryl-4-aminopyrimidine derivatives and pharmaceutical compositions containing the same
DE602004022946D1 (de) 4-cyanopyrazol-3-carbonsäureamidderivate, herstellung und therapeutische anwendung davon
IL178079A (en) History of phenyl 1-phenyl-4,3,2,1-tetrahydro-beta-carboline-2-carboxylate and medicinal preparations containing them
DE50204037D1 (de) Substituierte 1-oxa-2,8-diaza-spiro[4,5]dec-2-en-derivate als arzneimittel gegen schmerz
BRPI0508263B8 (pt) derivados de 1, 2, 3, 4-tetra-hidro-isoquinolina, composição farmacêutica, e, uso de derivado de 1, 2, 3, 4-tetra-hidro-isoquinolina
IL174479A (en) The derivatives of myastrin, pharmaceutical preparations containing them and their uses
HK1097256A1 (en) Pyrizdazine derivatives and their use as therapeutic agents
IL175252A0 (en) Benzimidazole derivatives and pharmaceutical compositions containing the same
AU2003289641A1 (en) The novel coumarin-amide derivatives and its preparation, said drug composition and its use
ATE356143T1 (de) Antibiotikum 107891, dessen faktoren a1 und a2, pharmazeutisch unbedenkliche salze und zusammensetzungen, und anwendung davon
ME01663B (me) Derivati N-(1H-indolil)-1H-indol-2-karboksamida, njihova priprema i njihova primena u terapiji
DE60130834D1 (de) Zusammensetzungen gegen schlechte Gerüche, deren Herstellung und Verwendung
DE60305037D1 (de) Piperazinylacylpiperidinderivate, deren herstellung und deren therapeutische anwendung
IS7088A (is) Nýjar afleiður oxasólidínóna sem bakteríueyðandi lyf
PL394604A1 (pl) Pochodna winyloazacykloalkanowa, jej zastosowanie oraz kompozycja farmaceutyczna
AU2003292422A1 (en) Oxazolidinone derivatives and their use as antibacterial agents
ZA200705495B (en) Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
HUP0500871A3 (en) 5-aryltetrazole compounds, compositions thereof and their use
IL166821A0 (en) Novel 1,4-diazabicycloalkane derivatives their preparation and use
DE60334632D1 (de) Mechanolumineszenzstoff und dessen herstellung
FR2873690B1 (fr) Derives d'oxopiperidine, leur preparation et leur application en therapeutique
IL181216A0 (en) 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
AU2002368487A1 (en) Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as tachykinin antagonists

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties